Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,069 | 127 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $250.01 | 13 | $0 (2024) |
| Lilly USA, LLC | $243.89 | 16 | $0 (2024) |
| Novo Nordisk Inc | $223.01 | 16 | $0 (2024) |
| Amgen Inc. | $203.93 | 16 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $133.31 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $131.44 | 8 | $0 (2024) |
| PFIZER INC. | $127.14 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $102.76 | 6 | $0 (2022) |
| Corium, LLC | $97.31 | 5 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $85.08 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $816.67 | 46 | Lilly USA, LLC ($151.16) |
| 2023 | $409.38 | 25 | PFIZER INC. ($65.15) |
| 2022 | $341.17 | 22 | Novo Nordisk Inc ($90.97) |
| 2021 | $502.19 | 34 | Amgen Inc. ($121.29) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes Care | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Food and Beverage | In-kind items and services | $69.57 | General |
| Category: Hypertension | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: PAIN | ||||||
| 09/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.82 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Gastroenterology | ||||||
| 08/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Bone Health | ||||||
| 06/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Gastroenterology | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Gastroenterology | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,202 | 1,347 | $103,716 | $48,209 |
| 2022 | 20 | 1,464 | 1,627 | $122,906 | $60,407 |
| 2021 | 18 | 1,087 | 1,130 | $87,599 | $43,773 |
| 2020 | 17 | 860 | 917 | $66,941 | $28,154 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 525 | 567 | $62,370 | $29,091 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 95 | $15,200 | $7,453 | 49.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 129 | 134 | $10,050 | $4,639 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 77 | 160 | $5,760 | $2,595 | 45.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 71 | 74 | $2,220 | $1,238 | 55.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 25 | $1,700 | $871.06 | 51.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 50 | 52 | $1,248 | $827.65 | 66.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 25 | 25 | $750.00 | $258.75 | 34.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 29 | $330.00 | $243.60 | 73.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 25 | $750.00 | $220.01 | 29.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 27 | 27 | $648.00 | $200.67 | 31.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 21 | $1,722 | $197.32 | 11.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 66 | 71 | $284.00 | $156.20 | 55.0% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 12 | 12 | $276.00 | $94.92 | 34.4% |
| 87081 | Screening test for pathogenic organisms | Office | 2023 | 12 | 12 | $228.00 | $78.00 | 34.2% |
| 85048 | Automated white blood cell count | Office | 2023 | 18 | 18 | $180.00 | $44.82 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 575 | 612 | $67,320 | $34,916 | 51.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 344 | 362 | $27,150 | $12,595 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 67 | $10,720 | $5,233 | 48.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 52 | 53 | $3,604 | $1,908 | 52.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 44 | 88 | $3,168 | $1,430 | 45.1% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2022 | 15 | 15 | $2,550 | $1,227 | 48.1% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 46 | 46 | $1,380 | $797.86 | 57.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 28 | 28 | $672.00 | $455.88 | 67.8% |
| 87081 | Screening test for pathogenic organisms | Office | 2022 | 35 | 40 | $760.00 | $261.72 | 34.4% |
About Nancy Broda, PAC
Nancy Broda, PAC is a Medical healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265625545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nancy Broda, PAC has received a total of $2,069 in payments from pharmaceutical and medical device companies, with $816.67 received in 2024. These payments were reported across 127 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,069).
As a Medicare-enrolled provider, Broda has provided services to 4,613 Medicare beneficiaries, totaling 5,021 services with total Medicare billing of $180,543. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Richmond, VA
- Active Since 08/21/2007
- Last Updated 04/28/2016
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1265625545
Products in Payments
- JARDIANCE (Drug) $190.11
- XIFAXAN (Drug) $133.31
- EVENITY (Biological) $130.23
- Rybelsus (Drug) $126.72
- FARXIGA (Drug) $106.94
- Ozempic (Drug) $96.29
- BREZTRI (Drug) $85.79
- NURTEC ODT (Drug) $80.12
- Azstarys (Drug) $76.37
- MOUNJARO (Drug) $72.56
- Tryvio (Drug) $69.57
- VYVANSE (Drug) $68.19
- REXULTI (Drug) $62.28
- FREESTYLE LIBRE 3 (Device) $52.11
- Heplisav-B (Drug) $48.39
- EMGALITY (Drug) $47.05
- QULIPTA (Drug) $46.37
- STIOLTO RESPIMAT (Drug) $35.89
- Aimovig (Biological) $35.25
- TRINTELLIX (Drug) $34.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Richmond
Sara Villalona, Pa, PA
Medical — Payments: $166,919
Janlyn Anthony, Pa-C, PA-C
Medical — Payments: $12,796
Nicholas Deptula, Pa-C, PA-C
Medical — Payments: $11,022
Lori Wood, Pa, PA
Medical — Payments: $9,226
Jenny Ambrosino, Pa, PA
Medical — Payments: $6,582
Thomas Cawley, Pa-C, PA-C
Medical — Payments: $6,421